Tripex Pharmaceuticals Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Tripex Pharmaceuticals General Information
Description
Developer of medicinal drugs designed to treat chronic pulmonary infections. The company's medicinal drugs offer an inhaled fluoroquinolone for the management of chronic pulmonary infections, enabling patients to access effective lungs infection treatment.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- United States
Tripex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 00.000 | Completed | Startup | |||
| 1. Early Stage VC | 30-Sep-2015 | 00.000 | 00.000 | Completed | Startup |